Livanova Plc
A global medical technology company that builds devices for cardiac surgery and neuromodulation, including VNS Therapy — an implanted system that sends gentle electrical pulses to the vagus nerve to help people with drug-resistant epilepsy have fewer seizures. It was created in 2015 when Houston's Cyberonics, a nerve-stimulation pioneer, merged with Italy's Sorin, a longtime maker of cardiac surgery equipment. The name blends "life" with the Latin "nova" (new), chosen from thousands of employee suggestions.
Granted 82.5K · Sold 10.0K
Granted 70.1K
Granted 41.9K · Bought 1.0K
Granted 31.6K
Granted 60.1K · Sold 64.6K
Granted 30.4K
Granted 1.3K
Granted 23.6K
Granted 13.6K
Granted 14.6K
Granted 9.5K
Granted 1.3K · Sold 3.0K
Granted 9.2K
Granted 4.9K
Granted 12.2K
Granted 11.9K · Sold 250
Granted 13.6K · Sold 7.3K
Granted 9.2K
Granted 4.7K
Granted 11.2K
Granted 13.6K
Granted 6.4K
Granted 9.3K
Granted 6.4K
Granted 2.6K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| McDonald DamienCEO, Director · 26 transactions | +48.7% | 116.2Kas of Mar 2023 | 82.5K | — | 10.0K |
| Shvartsburg AlexChief Financial Officer · 38 transactions | +1171.6% | 44.6K | 70.1K | — | — |
| Kozy William ADirector · 15 transactions | +618.9% | 38.2K | 41.9K | 1.0K | — |
| Bolton StephaniePresident, Global Epilepsy · 6 transactions | — | 30.6K | 31.6K | — | — |
| Moore Daniel JeffreyDirector · 15 transactions | -9.4% | 29.6Kas of Jun 2024 | 60.1K | — | 64.6K |
| Makatsaria VladimirChief Executive Officer, Director · 4 transactions | — | 25.3K | 30.4K | — | — |
| Rosenthal Arthur LDirector · 2 transactions | +5.5% | 23.6Kas of Jun 2022 | 1.3K | — | — |
| Hebbelinck TruiChief Human Resources Officer · 28 transactions | +1405.8% | 19.3Kas of Mar 2024 | 23.6K | — | — |
| Enxing Seng StacyDirector · 10 transactions | +316% | 15.8K | 13.6K | — | — |
| Schermerhorn Todd CDirector · 11 transactions | — | 13.1K | 14.6K | — | — |
| O'Kane SharonDirector · 8 transactions | +106.2% | 12.9Kas of Jun 2025 | 9.5K | — | — |
| Novak Alfred JDirector · 4 transactions | -12.1% | 12.6Kas of Jun 2022 | 1.3K | — | 3.0K |
| Poletti FrancoPresident, Cardiopulmonary · 13 transactions | — | 12.3K | 9.2K | — | — |
| Saia Andrea LynnDirector · 6 transactions | +59.4% | 10.8Kas of Dec 2023 | 4.9K | — | — |
| Wilver Peter MDirector · 8 transactions | — | 10.8K | 12.2K | — | — |
| Story BrookeDirector · 9 transactions | — | 10.3K | 11.9K | — | 250 |
| Bianchi FrancescoDirector · 15 transactions | +81.1% | 9.6K | 13.6K | — | 7.3K |
| Barry James ChristopherDirector · 6 transactions | — | 8.4K | 9.2K | — | — |
| Skeffington Keyna PidcockGeneral Counsel · 18 transactions | +45.9% | 8.1Kas of Sep 2022 | 4.7K | — | — |
| Hutchinson Michael DamonSVP, CLO and Company Secretary · 10 transactions | — | 7.9K | 11.2K | — | — |
| Dolci MarcoPresident CP · 22 transactions | — | 6.8Kas of Mar 2023 | 13.6K | — | — |
| Podlogar Susan MDirector · 4 transactions | — | 6.1K | 6.4K | — | — |
| Tezel AhmetChief Innovation Officer · 6 transactions | — | 6.1K | 9.3K | — | — |
| Kozmina NataliaChief Human Resources Officer · 2 transactions | — | 5.0K | 6.4K | — | — |
| Zurbay DonaldDirector · 2 transactions | — | 2.6K | 2.6K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -84.1K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.